Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningHematopoietic Stem Cell MobilizationHematologic NeoplasmsGraft vs Host DiseaseMelphalanGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisAntigens, CD34BusulfanBlood Component RemovalStem Cell TransplantationMultiple MyelomaCyclophosphamideTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsHematopoietic Stem CellsGraft SurvivalBone Marrow TransplantationLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionTissue DonorsRecurrenceCytophagocytosisCarmustineRetrospective StudiesSalvage TherapyImmunosuppressive AgentsIfosfamideHematopoiesisAmyloidosisVincristineCytomegalovirus InfectionsStem CellsCord Blood Stem Cell TransplantationHodgkin DiseaseCytarabineDisease-Free SurvivalTransplantation ChimeraNeoplasmsMicrovesselsWhole-Body IrradiationTime FactorsSurvival AnalysisInfectionHistocompatibilityHistocompatibility TestingLymphoma, T-CellDoxorubicinPOEMS SyndromePlatelet CountLeukemia, Myeloid, AcutePrednisoneLeukemiaCarboplatinVidarabineTransplantation, IsogeneicFollow-Up StudiesDexamethasoneRecombinant ProteinsBlood Cell CountAntineoplastic AgentsBlood CellsProspective StudiesLymphomaBone Marrow PurgingFatal OutcomeGraft vs Leukemia EffectFeasibility StudiesAnemia, AplasticMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunophenotypingOpportunistic InfectionsKidney TransplantationLymphocyte DepletionHematologic DiseasesT-LymphocytesCyclosporineBone MarrowBlood Transfusion, AutologousHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaLiver TransplantationImmunosuppressionPrognosisLeukocytes, MononuclearAntiviral AgentsFlow CytometryHistiocytosis, Non-Langerhans-CellBlood DonorsLivedo Reticularis